🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07284810
Enrolling by invitation Not applicable

Tracking Self-Reported Functional Needs and Quality of Life

NCT07284810 · tracked via the Priya Life Science USA tracker
Sponsor
Cionic, Inc.
Phase
Not applicable
Started
2025-11-26
Last updated
2025-12-17

Condition(s) studied

Upper Motor Neuron Disease

Investigational drug(s) / intervention(s)

Cionic Neural Sleeve System

Cionic Neural Sleeve System: The sleeve assists participants during physical activity by delivering electrical stimulation that helps contract the necessary muscles at the correct time to improve movement.

Study summary

The study aims to characterize the population of Cionic Neural Sleeve users and assess their health-related quality of life.

Eligibility

Sex
ALL
Min age
22 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Resident of the United States * New customer awaiting the Cionic Neural Sleeve Exclusion Criteria: * Implanted demand-type cardiac pacemaker or defibrillator * Malignant tumor or existing thrombosis in the impacted or more impacted leg * Fracture or dislocation in the impacted or more impacted leg that could be adversely affected by motion from stimulation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CIONIC San Francisco California

More Cionic, Inc. trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07284810 on ClinicalTrials.gov ↗ ← All trials in the USA